Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.
about
Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humansDifferentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biologyDissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strengthOsteoclasts: more than 'bone eaters'.Mutational analysis of NHAoc/NHA2 in Saccharomyces cerevisiae.A case of cavernous sinus thrombophlebitis and meningitis as a complication in osteopetrosisComplications of anesthesia for children with malignant infantile osteopetrosis before and after hematopoietic stem cell transplantationA novel missense mutation in the CLCN7 gene linked to benign autosomal dominant osteopetrosis: a case series.PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis.Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.Vacuolar ATPase in phagosome-lysosome fusion.Potential role of odanacatib in the treatment of osteoporosis.Building bone to reverse osteoporosis and repair fracturesExpression analysis of nha-oc/NHA2: a novel gene selectively expressed in osteoclastsOsteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.Hereditary and familial syndromes of bone and blood. Genetic pathways, diagnostic pitfalls.Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.Malignant infantile osteopetrosisOsteoclasts and hematopoiesis.Refined genomic localization of the genetic lesion in the osteopetrosis (op) rat and exclusion of three positional and functional candidate genes, Clcn7, Atp6v0c, and Slc9a3r2.Clinical and Radiological Findings of Autosomal Dominant Osteopetrosis Type II: A Case Report.Mechanisms of osteoclast-dependent bone formation.Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Osteoclast-derived coupling factors in bone remodeling.Osteopetrosis: genetics, treatment and new insights into osteoclast function.Interferon Gamma, but not Calcitriol Improves the Osteopetrotic Phenotypes in ADO2 Mice.Snx10: a newly identified locus associated with human osteopetrosisClinicoradiological findings of benign osteopetrosis: report of two new casesElevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders.The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice.Diagnostic dilemma: osteopetrosis with superimposed rickets causing neonatal hypocalcemia.Cervical spine fractures in osteopetrosis: a case report and review of the literature.Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II).Tuberous sclerosis, polycystic kidney disease and mucolipidosis III gamma caused by a microdeletion unmasking a recessive mutation.OsteopetrosisGenetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis
P2860
Q24673342-D3722BC2-D7D5-40B1-81E8-96AC84506A5FQ28303937-7B334C58-E5CC-4472-AA40-67AE052E7428Q28743063-42082812-0DD2-4FC9-825F-6945C77E8C3FQ33993757-A9721FB6-56D0-424A-A261-86E478533DA0Q34131430-091E4B16-5144-4C17-B53A-31DA039C0593Q34219224-215FC3C5-64F0-4632-BC34-6FAE5F62F5EDQ34296195-AF406C06-3564-4430-9D25-19724F64022DQ34321786-DD4DA834-C619-4F9B-80A0-4A366CDCC239Q34474147-3A09DC34-E332-4C06-AB2E-B1C24183A674Q35111940-FB9984A5-BF8F-4FF5-8FF7-9623FCC4442EQ35662382-8F930C21-FA03-4100-AE92-3B531B7DF161Q36136239-EAD82ABE-7198-40BE-AF27-783CC8270CD3Q36407024-2C8C88A2-D27B-4675-8A3A-9B6339139CEEQ36503261-93364D29-55E8-4F0E-8EC6-027EC4337F69Q36593362-2A4CFDE6-AB1F-4389-A726-2545C38427EFQ36871123-5057724A-1ECB-4412-AAB5-A5D6B07D6D3BQ36928118-C2D12333-61BD-4519-9989-A04BD837AB35Q37015968-23F70F9F-965B-4FC0-BFA1-1A556BFBA511Q37043697-59148492-CC8A-4DF4-B1F8-CCB7F85DBAE0Q37056351-71333063-D1FD-4803-B3DF-8839C65E8C15Q37283089-BD5F6F21-DFEE-4674-80A1-A27AC014402CQ37292206-E8D92710-5B0A-4760-B8C2-CB12C94FAF8FQ37414413-A4CA04C5-F279-40F4-9AC8-C8E096998183Q37467923-0368A22E-1D34-438E-9B89-DA5CD921C118Q38093799-CC256EF6-F2CE-4898-9A56-BCA1308FACF3Q38108750-7AEA4998-AC10-4903-A0DD-9C3DECEEB84AQ38123371-28F1BE29-DF16-41E2-A7C8-699BAA7E6DC3Q40973847-C67B80B0-8951-45A9-B8C1-F1D64C6619E7Q41875402-479FBE78-89A4-4561-8917-65010AE53FABQ42428076-FBC24AF4-918E-4A8F-B69A-A73B27D9FE38Q43055107-C06EE9A6-430C-483E-9951-1298102F69C2Q45222983-751626F0-F9C5-4F95-99FC-E8F2704A6507Q47746410-F84E8367-EDEA-4EA5-8866-9F9CDD3A4CE0Q49895104-779BBBE5-6CF3-48BD-8F14-0EA05D3B7D2CQ50091703-B541015C-79B0-4169-BD7F-0779857B71A1Q54982276-A2B38329-1AA6-4562-A778-93B7866F2CE0Q56335726-C32422F6-8E70-4D0C-87B8-F576FEAF4E87Q57213222-9F803E8A-38A1-4638-9374-0455B23FFC0F
P2860
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical, genetic, and cellula ...... s for diagnosis and treatment.
@en
type
label
Clinical, genetic, and cellula ...... s for diagnosis and treatment.
@en
prefLabel
Clinical, genetic, and cellula ...... s for diagnosis and treatment.
@en
P2093
P2860
P50
P356
P1476
Clinical, genetic, and cellula ...... ns for diagnosis and treatment
@en
P2093
D Fortunati
G Bianchini
H Fryssira
M Caniglia
P2860
P304
P356
10.1136/JMG.2005.036673
P407
P577
2005-08-23T00:00:00Z